This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The $1,918.44 firm fixed-price contract has a completion date of May 19, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.96, is for the delivery of VAXELIS vaccine syringes (0.5 mL) and has a completion date of February 12, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. In addition to this delivery order, AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.92 firm fixed-price contract is for the delivery of the VAXELIS vaccine syringe 0.5 ML. The award has an ultimate completion date of February 4, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the VAXELIS vaccine syringe 0.5ML, with a ceiling value of $1,278.96 and a completion date of December 27, 2024. The contract is a firm-fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a for-profit organization registered in...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,394.80, is for the delivery of VAXELIS vaccine syringes (0.5mL) and has an ultimate completion date of March 25, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This delivery order contract, valued at $1,239.24, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The contract is for the provision of VAXELIS vaccine syringes (0.5 mL) to be delivered by January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,743.09, is for the delivery of VAXELIS vaccine syringes (0.5 mL) to support military healthcare programs. The contract is a firm fixed-price arrangement with a completion date of January 31, 2025. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the VAXELIS vaccine in 0.5 mL vials. The $14,741.19 firm fixed-price contract has a completion date of May 22, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of VAXELIS vaccine syringes. The contract has a firm fixed price of $4,956.96 and an ultimate completion date of September 17, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds significant indefinite delivery contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range of medical commodities,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.96, is for the delivery of VAXELIS vaccine syringes (0.5 mL) and has an ultimate completion date of April 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...